Date: 2025-10-02Category: Not ApplicableState: Union GovernmentCountry: Europe
Decision of the EEA Joint Committee No 130/2025 of 13 June 2025 amending Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement [2025/1852]
**Executive Summary**
This is the Decision of the EEA Joint Committee No 130/2025 of 13 June 2025, amending Annex II to the EEA Agreement, to incorporate and repeal several EU Commission Implementing Regulations and Decisions regarding biocidal products. The decision enters into force on 14 June 2025, subject to the completion of all notifications under Article 103(1) of the EEA Agreement.
**Key Points / Main Content**
* **Amendment of Annex II, Chapter XV:**
* **Incorporation of Decisions/Regulations:**
* Implementing Decision (EU) 2025/349 (Spinosad, product-type 18)
* Implementing Decision (EU) 2025/357 (5-chloro-2-methyl-2H-isothiazol-3-one, product-type 6)
* Implementing Decision (EU) 2025/360 (Bromoacetic acid, product-type 4)
* Implementing Decision (EU) 2025/362 (Cypermethrin, product-type 8)
* Implementing Decision (EU) 2025/432 (Copper sulphate pentahydrate, product-type 2)
* Implementing Decision (EU) 2025/434 (Etofenprox, product-type 18)
* Implementing Decision (EU) 2025/444 (Benzoic acid, product-types 3 and 4)
* Implementing Decision (EU) 2025/450 (IPBC, product-type 6)
* Implementing Regulation (EU) 2025/457 (Dinotefuran, product-type 18)
* Implementing Decision (EU) 2025/461 (Aluminium phosphide releasing phosphine, product-type 20)
* **Repeal of a Decision:**
* Point 12zzzzzzzzzzzf, which references Implementing Decision (EU) 2024/2410 is deleted as it is repealed by Implementing Decision (EU) 2025/459.
* **Authentic Languages:**
* The texts of the listed Regulations and Decisions shall be authentic in Icelandic and Norwegian.
* **Entry into Force:**
* The decision enters into force on 14 June 2025, pending required notifications.
* **Publication:**
* The decision will be published in the EEA Section and Supplement of the Official Journal of the European Union.
**Impact Analysis**
**EEA Member States**
**Impact**
* EEA member states are obligated to incorporate the amended Annex II into their national legislation.
**Action Required**
* Ensure alignment of national regulations with the updated Annex II of the EEA Agreement.
* Implement and enforce the updated regulations concerning biocidal products.
**Biocidal Product Manufacturers/Suppliers**
**Impact**
* Manufacturers and suppliers of biocidal products within the EEA must comply with the updated regulations regarding active substances and product types.
**Action Required**
* Review and adapt product formulations and labeling to comply with the new expiry dates or approval status of active substances.
* Ensure continued compliance with Regulation (EU) No 528/2012.
**European Parliament and Council**
**Impact**
* The European Parliament and Council are the institutions that issued the decisions which are now incorporated into the EEA Agreement.
**Action Required**
* No direct action required based on the document.
Key Entities Referenced
EEA Agreement: Agreement on the European Economic Area (EEA)
Regulation (EU) No 528/2012: Regulation concerning the making available on the market and use of biocidal products.
Annex II (Technical regulations, standards, testing and certification): Annex to the EEA Agreement that is amended by this Decision.
EEA Joint Committee: The decision-making body responsible for amending the EEA Agreement.
Official Journal EN
of the European Union L series
2025/1852 2.10.2025
DECISION OF THE EEA JOINT COMMITTEENo 130/2025
of 13 June 2025
amending Annex II (Technical regulations, standards, testing and certification) to the
EEA Agreement [2025/1852]
THE EEA JOINT COMMITTEE,
Having regard to the Agreement on the European Economic Area (“the EEA Agreement”), and in particular Article 98
thereof,
Whereas:
(1) Commission Implementing Regulation (EU) 2025/457 of 10 March 2025 renewing the approval of dinotefuran as an
active substance for use in biocidal products of product-type 18 in accordance with Regulation (EU) No 528/2012 of
the European Parliament and of the Council(1)is to be incorporated into the EEA Agreement.
(2) Commission Implementing Decision (EU) 2025/349 of 21 February 2025 postponing the expiry date of the approval
of spinosad for use in biocidal products of product-type 18 in accordance with Regulation (EU) No 528/2012 of the
European Parliament and of the Council(2)is to be incorporated into the EEA Agreement.
(3) Commission Implementing Decision (EU) 2025/357 of 21 February 2025 not approving 5-chloro-2-methyl-2H-
isothiazol-3-one (CIT) as an active substance for use in biocidal products of product-type 6 in accordance with
Regulation (EU) No 528/2012 of the European Parliament and of the Council(3)is to be incorporated into the EEA
Agreement.
(4) Commission Implementing Decision (EU) 2025/360 of 21 February 2025 postponing the expiry date of the approval
of bromoacetic acid for use in biocidal products of product-type 4 in accordance with Regulation (EU) No 528/2012
of the European Parliament and of the Council(4)is to be incorporated into the EEA Agreement.
(5) Commission Implementing Decision (EU) 2025/362 of 21 February 2025 postponing the expiry date of the approval
of cypermethrin for use in biocidal products of product-type 8 in accordance with Regulation (EU) No 528/2012 of
the European Parliament and of the Council(5)is to be incorporated into the EEA Agreement.
(6) Commission Implementing Decision (EU) 2025/432 of 5 March 2025 postponing the expiry date of the approval of
copper sulphate pentahydrate for use in biocidal products of product-type 2 in accordance with Regulation (EU)
No 528/2012 of the European Parliament and of the Council(6)is to be incorporated into the EEA Agreement.
(7) Commission Implementing Decision (EU) 2025/434 of 5 March 2025 postponing the expiry date of the approval of
etofenprox for use in biocidal products of product-type 18 in accordance with Regulation (EU) No 528/2012 of the
European Parliament and of the Council(7)is to be incorporated into the EEA Agreement.
(8) Commission Implementing Decision (EU) 2025/444 of 5 March 2025 postponing the expiry date of the approval of
benzoic acid for use in biocidal products of product-types 3 and 4 in accordance with Regulation (EU) No 528/2012
of the European Parliament and of the Council(8)is to be incorporated into the EEA Agreement.
(1) OJ L, 2025/457, 11.3.2025, ELI: http://data.europa.eu/eli/reg_impl/2025/457/oj.
(2) OJ L, 2025/349, 24.2.2025, ELI: http://data.europa.eu/eli/dec_impl/2025/349/oj.
(3) OJ L, 2025/357, 24.2.2025, ELI: http://data.europa.eu/eli/dec_impl/2025/357/oj.
(4) OJ L, 2025/360, 25.2.2025, ELI: http://data.europa.eu/eli/dec_impl/2025/360/oj.
(5) OJ L, 2025/362, 24.2.2025, ELI: http://data.europa.eu/eli/dec_impl/2025/362/oj.
(6) OJ L, 2025/432, 6.3.2025, ELI: http://data.europa.eu/eli/dec_impl/2025/432/oj.
(7) OJ L, 2025/434, 6.3.2025, ELI: http://data.europa.eu/eli/dec_impl/2025/434/oj.
(8) OJ L, 2025/444, 7.3.2025, ELI: http://data.europa.eu/eli/dec_impl/2025/444/oj.
ELI: http://data.europa.eu/eli/dec/2025/1852/oj 1/3EN
OJ L, 2.10.2025
(9) Commission Implementing Decision (EU) 2025/450 of 6 March 2025 postponing the expiry date of the approval of
IPBC for use in biocidal products of product-type 6 in accordance with Regulation (EU) No 528/2012 of the
European Parliament and of the Council(9)is to be incorporated into the EEA Agreement.
(10) Commission Implementing Decision (EU) 2025/459 of 10 March 2025 repealing Implementing Decision
(EU) 2024/2410 postponing the expiry date of the approval of dinotefuran for use in biocidal products of product-
type 18 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council(10)is to be
incorporated into the EEA Agreement.
(11) Commission Implementing Decision (EU) 2025/461 of 10 March 2025 postponing the expiry date of the approval
of aluminium phosphide releasing phosphine for use in biocidal products of product-type 20 in accordance with
Regulation (EU) No 528/2012 of the European Parliament and of the Council(11)is to be incorporated into the EEA
Agreement.
(12) Implementing Decision (EU) 2025/459 repeals Commission Implementing Decision (EU) 2024/2410(12), which is
incorporated into the EEA Agreement and which is consequently to be repealed under the EEA Agreement.
(13) Annex II to the EEA Agreement should therefore be amended accordingly,
HAS ADOPTED THIS DECISION:
Article 1
Chapter XV of Annex II is amended as follows:
1. The following points are inserted after point 12zzzzzzzzzzzp (Commission Implementing Decision (EU) 2024/2948)
of Chapter XV of Annex II to the EEA Agreement:
‘12zzzzzzzzzzzq.32025 D 0349: Commission Implementing Decision (EU) 2025/349 of 21 February 2025
postponing the expiry date of the approval of spinosad for use in biocidal products of product-
type 18 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the
Council (OJ L, 2025/349, 24.2.2025).
12zzzzzzzzzzzr. 32025 D 0357: Commission Implementing Decision (EU) 2025/357 of 21 February 2025 not
approving 5-chloro-2-methyl-2H-isothiazol-3-one (CIT) as an active substance for use in biocidal
products of product-type 6 in accordance with Regulation (EU) No 528/2012 of the European
Parliament and of the Council (OJ L, 2025/357, 24.2.2025).
12zzzzzzzzzzzs. 32025 D 0360: Commission Implementing Decision (EU) 2025/360 of 21 February 2025
postponing the expiry date of the approval of bromoacetic acid for use in biocidal products of
product-type 4 in accordance with Regulation (EU) No 528/2012 of the European Parliament and
of the Council (OJ L, 2025/360, 25.2.2025).
12zzzzzzzzzzzt. 32025 D 0362: Commission Implementing Decision (EU) 2025/362 of 21 February 2025
postponing the expiry date of the approval of cypermethrin for use in biocidal products of
product-type 8 in accordance with Regulation (EU) No 528/2012 of the European Parliament and
of the Council (OJ L, 2025/362, 24.2.2025).
12zzzzzzzzzzzu. 32025 D 0432: Commission Implementing Decision (EU) 2025/432 of 5 March 2025 postponing
the expiry date of the approval of copper sulphate pentahydrate for use in biocidal products of
product-type 2 in accordance with Regulation (EU) No 528/2012 of the European Parliament and
of the Council (OJ L, 2025/432, 6.3.2025).
(9) OJ L, 2025/450, 7.3.2025, ELI: http://data.europa.eu/eli/dec_impl/2025/450/oj.
(10) OJ L, 2025/459, 11.3.2025, ELI: http://data.europa.eu/eli/dec_impl/2025/459/oj.
(11) OJ L, 2025/461, 11.3.2025, ELI: http://data.europa.eu/eli/dec_impl/2025/461/oj.
(12) OJ L, 2024/2410, 16.9.2024, ELI: http://data.europa.eu/eli/dec_impl/2024/2410/oj.
2/3 ELI: http://data.europa.eu/eli/dec/2025/1852/ojEN
OJ L, 2.10.2025
12zzzzzzzzzzzv. 32025 D 0434: Commission Implementing Decision (EU) 2025/434 of 5 March 2025 postponing
the expiry date of the approval of etofenprox for use in biocidal products of product-type 18 in
accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council (OJ
L, 2025/434, 6.3.2025).
12zzzzzzzzzzzw.32025 D 0444: Commission Implementing Decision (EU) 2025/444 of 5 March 2025 postponing
the expiry date of the approval of benzoic acid for use in biocidal products of product-types 3
and 4 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the
Council (OJ L, 2025/444, 7.3.2025).
12zzzzzzzzzzzx. 32025 D 0450: Commission Implementing Decision (EU) 2025/450 of 6 March 2025 postponing
the expiry date of the approval of IPBC for use in biocidal products of product-type 6 in accordance
with Regulation (EU) No 528/2012 of the European Parliament and of the Council (OJ L,
2025/450, 7.3.2025).
12zzzzzzzzzzzy. 32025 R 0457: Commission Implementing Regulation (EU) 2025/457 of 10 March 2025
renewing the approval of dinotefuran as an active substance for use in biocidal products of
product-type 18 in accordance with Regulation (EU) No 528/2012 of the European Parliament
and of the Council (OJ L, 2025/457, 11.3.2025).
12zzzzzzzzzzzz. 32025 D 0461: Commission Implementing Decision (EU) 2025/461 of 10 March 2025
postponing the expiry date of the approval of aluminium phosphide releasing phosphine for use
in biocidal products of product-type 20 in accordance with Regulation (EU) No 528/2012 of the
European Parliament and of the Council (OJ L, 2025/461, 11.3.2025).’
2. The text of point 12zzzzzzzzzzzf (Commission Implementing Decision (EU) 2024/2410) is deleted.
Article 2
The texts of Implementing Regulation (EU) 2025/457 and Implementing Decisions (EU) 2025/349, (EU) 2025/357,
(EU) 2025/360, (EU) 2025/362, (EU) 2025/432, (EU) 2025/434, (EU) 2025/444, (EU) 2025/450, (EU) 2025/459 and
(EU) 2025/461 in the Icelandic and Norwegian languages, to be published in the EEA Supplement to the Official Journal of
the European Union, shall be authentic.
Article 3
This Decision shall enter into force on 14 June 2025, provided that all the notifications under Article 103(1) of the EEA
Agreement have been made(*).
Article 4
This Decision shall be published in the EEA Section of, and in the EEA Supplement to, the Official Journal of the European
Union.
Done at Brussels, 13 June 2025.
For the EEA Joint Committee
The President
Nicolas VON LINGEN
(*) No constitutional requirements indicated.
ELI: http://data.europa.eu/eli/dec/2025/1852/oj 3/3